nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Tetrahydrofolic acid—ALDH1L1—obesity	0.0105	0.716	CrCbGaD
Pemetrexed—GART—islet of Langerhans—obesity	0.00979	0.0455	CbGeAlD
Pemetrexed—GART—respiratory system—obesity	0.00924	0.0429	CbGeAlD
Pemetrexed—GART—adrenal cortex—obesity	0.00776	0.036	CbGeAlD
Pemetrexed—GART—cardiovascular system—obesity	0.00708	0.0329	CbGeAlD
Pemetrexed—SLC46A1—adrenal cortex—obesity	0.0063	0.0293	CbGeAlD
Pemetrexed—ATIC—respiratory system—obesity	0.00628	0.0292	CbGeAlD
Pemetrexed—GART—pituitary gland—obesity	0.00627	0.0291	CbGeAlD
Pemetrexed—GART—adipose tissue—obesity	0.00624	0.029	CbGeAlD
Pemetrexed—GART—digestive system—obesity	0.00588	0.0273	CbGeAlD
Pemetrexed—TYMS—Alverine—Benzphetamine—obesity	0.00568	1	CbGdCrCtD
Pemetrexed—GART—adrenal gland—obesity	0.0056	0.026	CbGeAlD
Pemetrexed—SLC46A1—pituitary gland—obesity	0.00509	0.0236	CbGeAlD
Pemetrexed—GART—endocrine gland—obesity	0.00486	0.0226	CbGeAlD
Pemetrexed—ATIC—cardiovascular system—obesity	0.00481	0.0223	CbGeAlD
Pemetrexed—SLC46A1—digestive system—obesity	0.00477	0.0222	CbGeAlD
Pemetrexed—SLC46A1—adrenal gland—obesity	0.00455	0.0211	CbGeAlD
Pemetrexed—GART—liver—obesity	0.00438	0.0203	CbGeAlD
Pemetrexed—TYMS—respiratory system—obesity	0.00426	0.0198	CbGeAlD
Pemetrexed—ATIC—adipose tissue—obesity	0.00424	0.0197	CbGeAlD
Pemetrexed—DHFR—respiratory system—obesity	0.00421	0.0196	CbGeAlD
Pemetrexed—SLC29A1—islet of Langerhans—obesity	0.00404	0.0188	CbGeAlD
Pemetrexed—ATIC—digestive system—obesity	0.00399	0.0185	CbGeAlD
Pemetrexed—SLC46A1—endocrine gland—obesity	0.00394	0.0183	CbGeAlD
Pemetrexed—DCK—islet of Langerhans—obesity	0.00386	0.0179	CbGeAlD
Pemetrexed—SLC29A1—respiratory system—obesity	0.00382	0.0177	CbGeAlD
Pemetrexed—ATIC—adrenal gland—obesity	0.0038	0.0177	CbGeAlD
Pemetrexed—SLC46A1—liver—obesity	0.00355	0.0165	CbGeAlD
Pemetrexed—DHFR—adrenal cortex—obesity	0.00354	0.0164	CbGeAlD
Pemetrexed—ATIC—endocrine gland—obesity	0.0033	0.0153	CbGeAlD
Pemetrexed—DHFR—cardiovascular system—obesity	0.00323	0.015	CbGeAlD
Pemetrexed—SLC29A1—adrenal cortex—obesity	0.0032	0.0149	CbGeAlD
Pemetrexed—DCK—adrenal cortex—obesity	0.00306	0.0142	CbGeAlD
Pemetrexed—ATIC—liver—obesity	0.00297	0.0138	CbGeAlD
Pemetrexed—SLC29A1—cardiovascular system—obesity	0.00292	0.0136	CbGeAlD
Pemetrexed—TYMS—adipose tissue—obesity	0.00287	0.0134	CbGeAlD
Pemetrexed—DHFR—pituitary gland—obesity	0.00286	0.0133	CbGeAlD
Pemetrexed—DHFR—adipose tissue—obesity	0.00285	0.0132	CbGeAlD
Pemetrexed—TYMS—digestive system—obesity	0.00271	0.0126	CbGeAlD
Pemetrexed—DHFR—digestive system—obesity	0.00268	0.0125	CbGeAlD
Pemetrexed—SLC29A1—pituitary gland—obesity	0.00259	0.012	CbGeAlD
Pemetrexed—TYMS—adrenal gland—obesity	0.00258	0.012	CbGeAlD
Pemetrexed—SLC29A1—adipose tissue—obesity	0.00258	0.012	CbGeAlD
Pemetrexed—DHFR—adrenal gland—obesity	0.00255	0.0119	CbGeAlD
Pemetrexed—DCK—pituitary gland—obesity	0.00247	0.0115	CbGeAlD
Pemetrexed—DCK—adipose tissue—obesity	0.00246	0.0114	CbGeAlD
Pemetrexed—SLC29A1—digestive system—obesity	0.00243	0.0113	CbGeAlD
Pemetrexed—DCK—digestive system—obesity	0.00232	0.0108	CbGeAlD
Pemetrexed—SLC29A1—adrenal gland—obesity	0.00231	0.0107	CbGeAlD
Pemetrexed—TYMS—endocrine gland—obesity	0.00224	0.0104	CbGeAlD
Pemetrexed—DHFR—endocrine gland—obesity	0.00221	0.0103	CbGeAlD
Pemetrexed—DCK—adrenal gland—obesity	0.00221	0.0103	CbGeAlD
Pemetrexed—TYMS—liver—obesity	0.00202	0.00937	CbGeAlD
Pemetrexed—SLC29A1—endocrine gland—obesity	0.00201	0.00932	CbGeAlD
Pemetrexed—DHFR—liver—obesity	0.002	0.00928	CbGeAlD
Pemetrexed—DCK—endocrine gland—obesity	0.00192	0.0089	CbGeAlD
Pemetrexed—SLC29A1—liver—obesity	0.00181	0.0084	CbGeAlD
Pemetrexed—DCK—liver—obesity	0.00173	0.00803	CbGeAlD
Pemetrexed—Lacrimation increased—Topiramate—obesity	0.00119	0.00325	CcSEcCtD
Pemetrexed—Constipation—Diethylpropion—obesity	0.00119	0.00323	CcSEcCtD
Pemetrexed—Mood swings—Bupropion—obesity	0.00119	0.00323	CcSEcCtD
Pemetrexed—Folic Acid—MTHFR—obesity	0.00118	0.0808	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—obesity	0.00118	0.0808	CrCbGaD
Pemetrexed—Dehydration—Bupropion—obesity	0.00117	0.00317	CcSEcCtD
Pemetrexed—Nausea—Phendimetrazine—obesity	0.00116	0.00316	CcSEcCtD
Pemetrexed—Creatinine increased—Topiramate—obesity	0.00116	0.00314	CcSEcCtD
Pemetrexed—Asthenia—Phentermine—obesity	0.00115	0.00312	CcSEcCtD
Pemetrexed—Infestation NOS—Orlistat—obesity	0.00114	0.00311	CcSEcCtD
Pemetrexed—Infestation—Orlistat—obesity	0.00114	0.00311	CcSEcCtD
Pemetrexed—Fatigue—Cimetidine—obesity	0.00114	0.0031	CcSEcCtD
Pemetrexed—Constipation—Cimetidine—obesity	0.00113	0.00308	CcSEcCtD
Pemetrexed—Renal failure—Orlistat—obesity	0.00112	0.00306	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Orlistat—obesity	0.00112	0.00305	CcSEcCtD
Pemetrexed—Urticaria—Diethylpropion—obesity	0.0011	0.003	CcSEcCtD
Pemetrexed—Dizziness—Phenylpropanolamine—obesity	0.0011	0.003	CcSEcCtD
Pemetrexed—Pulmonary embolism—Topiramate—obesity	0.0011	0.00299	CcSEcCtD
Pemetrexed—Diarrhoea—Phentermine—obesity	0.00109	0.00297	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Sibutramine—obesity	0.00109	0.00297	CcSEcCtD
Pemetrexed—Renal failure—Sibutramine—obesity	0.00109	0.00296	CcSEcCtD
Pemetrexed—Myocardial infarction—Sibutramine—obesity	0.00109	0.00295	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Sibutramine—obesity	0.00109	0.00295	CcSEcCtD
Pemetrexed—Dysphagia—Bupropion—obesity	0.00108	0.00295	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Orlistat—obesity	0.00108	0.00294	CcSEcCtD
Pemetrexed—Stomatitis—Sibutramine—obesity	0.00108	0.00294	CcSEcCtD
Pemetrexed—Conjunctivitis—Sibutramine—obesity	0.00108	0.00293	CcSEcCtD
Pemetrexed—Pancreatitis—Bupropion—obesity	0.00106	0.00289	CcSEcCtD
Pemetrexed—Vomiting—Phenylpropanolamine—obesity	0.00106	0.00289	CcSEcCtD
Pemetrexed—Dizziness—Phentermine—obesity	0.00106	0.00287	CcSEcCtD
Pemetrexed—Rash—Phenylpropanolamine—obesity	0.00105	0.00286	CcSEcCtD
Pemetrexed—Dermatitis—Phenylpropanolamine—obesity	0.00105	0.00286	CcSEcCtD
Pemetrexed—Body temperature increased—Cimetidine—obesity	0.00104	0.00284	CcSEcCtD
Pemetrexed—Neuropathy—Topiramate—obesity	0.00103	0.00281	CcSEcCtD
Pemetrexed—Pancytopenia—Bupropion—obesity	0.00103	0.0028	CcSEcCtD
Pemetrexed—Hepatitis—Orlistat—obesity	0.00103	0.0028	CcSEcCtD
Pemetrexed—Pharyngitis—Orlistat—obesity	0.00102	0.00277	CcSEcCtD
Pemetrexed—Vomiting—Phentermine—obesity	0.00102	0.00276	CcSEcCtD
Pemetrexed—Urinary tract disorder—Orlistat—obesity	0.00101	0.00276	CcSEcCtD
Pemetrexed—Urethral disorder—Orlistat—obesity	0.00101	0.00274	CcSEcCtD
Pemetrexed—Rash—Phentermine—obesity	0.00101	0.00274	CcSEcCtD
Pemetrexed—Dermatitis—Phentermine—obesity	0.00101	0.00274	CcSEcCtD
Pemetrexed—Oesophagitis—Topiramate—obesity	0.001	0.00273	CcSEcCtD
Pemetrexed—Nausea—Phenylpropanolamine—obesity	0.000991	0.0027	CcSEcCtD
Pemetrexed—Pharyngitis—Sibutramine—obesity	0.000987	0.00268	CcSEcCtD
Pemetrexed—Hypersensitivity—Cimetidine—obesity	0.000974	0.00265	CcSEcCtD
Pemetrexed—Infestation NOS—Bupropion—obesity	0.000965	0.00263	CcSEcCtD
Pemetrexed—Infestation—Bupropion—obesity	0.000965	0.00263	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Bupropion—obesity	0.000957	0.0026	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Bupropion—obesity	0.000952	0.00259	CcSEcCtD
Pemetrexed—Diarrhoea—Diethylpropion—obesity	0.000951	0.00259	CcSEcCtD
Pemetrexed—Nausea—Phentermine—obesity	0.000949	0.00258	CcSEcCtD
Pemetrexed—Asthenia—Cimetidine—obesity	0.000948	0.00258	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Bupropion—obesity	0.000946	0.00258	CcSEcCtD
Pemetrexed—Myocardial infarction—Bupropion—obesity	0.000946	0.00258	CcSEcCtD
Pemetrexed—Stomatitis—Bupropion—obesity	0.000941	0.00256	CcSEcCtD
Pemetrexed—Conjunctivitis—Bupropion—obesity	0.000938	0.00255	CcSEcCtD
Pemetrexed—Eye disorder—Sibutramine—obesity	0.000929	0.00253	CcSEcCtD
Pemetrexed—Dizziness—Diethylpropion—obesity	0.000919	0.0025	CcSEcCtD
Pemetrexed—Alopecia—Orlistat—obesity	0.000908	0.00247	CcSEcCtD
Pemetrexed—Diarrhoea—Cimetidine—obesity	0.000904	0.00246	CcSEcCtD
Pemetrexed—Malnutrition—Orlistat—obesity	0.000894	0.00243	CcSEcCtD
Pemetrexed—Arrhythmia—Sibutramine—obesity	0.000888	0.00242	CcSEcCtD
Pemetrexed—Vomiting—Diethylpropion—obesity	0.000883	0.0024	CcSEcCtD
Pemetrexed—Alopecia—Sibutramine—obesity	0.000878	0.00239	CcSEcCtD
Pemetrexed—Rash—Diethylpropion—obesity	0.000876	0.00238	CcSEcCtD
Pemetrexed—Dysgeusia—Orlistat—obesity	0.000876	0.00238	CcSEcCtD
Pemetrexed—Dermatitis—Diethylpropion—obesity	0.000875	0.00238	CcSEcCtD
Pemetrexed—Dizziness—Cimetidine—obesity	0.000874	0.00238	CcSEcCtD
Pemetrexed—Hepatitis—Bupropion—obesity	0.000867	0.00236	CcSEcCtD
Pemetrexed—Malnutrition—Sibutramine—obesity	0.000865	0.00235	CcSEcCtD
Pemetrexed—Pharyngitis—Bupropion—obesity	0.00086	0.00234	CcSEcCtD
Pemetrexed—Urinary tract disorder—Bupropion—obesity	0.000856	0.00233	CcSEcCtD
Pemetrexed—Urethral disorder—Bupropion—obesity	0.00085	0.00231	CcSEcCtD
Pemetrexed—Dysgeusia—Sibutramine—obesity	0.000847	0.00231	CcSEcCtD
Pemetrexed—Vomiting—Cimetidine—obesity	0.00084	0.00229	CcSEcCtD
Pemetrexed—Rash—Cimetidine—obesity	0.000833	0.00227	CcSEcCtD
Pemetrexed—Dermatitis—Cimetidine—obesity	0.000833	0.00227	CcSEcCtD
Pemetrexed—Nausea—Diethylpropion—obesity	0.000825	0.00225	CcSEcCtD
Pemetrexed—Erythema multiforme—Bupropion—obesity	0.000819	0.00223	CcSEcCtD
Pemetrexed—Methotrexate—MTHFR—obesity	0.00081	0.0553	CrCbGaD
Pemetrexed—Eye disorder—Bupropion—obesity	0.00081	0.0022	CcSEcCtD
Pemetrexed—Anaemia—Sibutramine—obesity	0.0008	0.00218	CcSEcCtD
Pemetrexed—Nausea—Cimetidine—obesity	0.000785	0.00214	CcSEcCtD
Pemetrexed—Syncope—Sibutramine—obesity	0.000776	0.00211	CcSEcCtD
Pemetrexed—Leukopenia—Sibutramine—obesity	0.000775	0.00211	CcSEcCtD
Pemetrexed—Arrhythmia—Bupropion—obesity	0.000774	0.00211	CcSEcCtD
Pemetrexed—Alopecia—Bupropion—obesity	0.000766	0.00208	CcSEcCtD
Pemetrexed—Chest pain—Orlistat—obesity	0.000761	0.00207	CcSEcCtD
Pemetrexed—Myalgia—Orlistat—obesity	0.000761	0.00207	CcSEcCtD
Pemetrexed—Loss of consciousness—Sibutramine—obesity	0.000761	0.00207	CcSEcCtD
Pemetrexed—Mood swings—Topiramate—obesity	0.000756	0.00206	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000756	0.00206	CcSEcCtD
Pemetrexed—Malnutrition—Bupropion—obesity	0.000754	0.00205	CcSEcCtD
Pemetrexed—Blood creatinine increased—Topiramate—obesity	0.000748	0.00203	CcSEcCtD
Pemetrexed—Hypertension—Sibutramine—obesity	0.000747	0.00203	CcSEcCtD
Pemetrexed—Dehydration—Topiramate—obesity	0.000742	0.00202	CcSEcCtD
Pemetrexed—Dysgeusia—Bupropion—obesity	0.000739	0.00201	CcSEcCtD
Pemetrexed—Arthralgia—Sibutramine—obesity	0.000737	0.002	CcSEcCtD
Pemetrexed—Chest pain—Sibutramine—obesity	0.000737	0.002	CcSEcCtD
Pemetrexed—Myalgia—Sibutramine—obesity	0.000737	0.002	CcSEcCtD
Pemetrexed—Oedema—Orlistat—obesity	0.00073	0.00199	CcSEcCtD
Pemetrexed—Anaphylactic shock—Orlistat—obesity	0.00073	0.00199	CcSEcCtD
Pemetrexed—Infection—Orlistat—obesity	0.000725	0.00197	CcSEcCtD
Pemetrexed—Folic Acid—CYP2E1—obesity	0.00072	0.0491	CrCbGaD
Pemetrexed—Aspartate aminotransferase increased—Topiramate—obesity	0.000719	0.00196	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Topiramate—obesity	0.000719	0.00196	CcSEcCtD
Pemetrexed—Nervous system disorder—Orlistat—obesity	0.000716	0.00195	CcSEcCtD
Pemetrexed—Skin disorder—Orlistat—obesity	0.000709	0.00193	CcSEcCtD
Pemetrexed—Anaphylactic shock—Sibutramine—obesity	0.000706	0.00192	CcSEcCtD
Pemetrexed—Oedema—Sibutramine—obesity	0.000706	0.00192	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Topiramate—obesity	0.000704	0.00192	CcSEcCtD
Pemetrexed—Infection—Sibutramine—obesity	0.000702	0.00191	CcSEcCtD
Pemetrexed—Anaemia—Bupropion—obesity	0.000697	0.0019	CcSEcCtD
Pemetrexed—Shock—Sibutramine—obesity	0.000695	0.00189	CcSEcCtD
Pemetrexed—Thrombocytopenia—Sibutramine—obesity	0.000692	0.00188	CcSEcCtD
Pemetrexed—Dysphagia—Topiramate—obesity	0.00069	0.00188	CcSEcCtD
Pemetrexed—Skin disorder—Sibutramine—obesity	0.000686	0.00187	CcSEcCtD
Pemetrexed—Syncope—Bupropion—obesity	0.000677	0.00184	CcSEcCtD
Pemetrexed—Pancreatitis—Topiramate—obesity	0.000676	0.00184	CcSEcCtD
Pemetrexed—Leukopenia—Bupropion—obesity	0.000675	0.00184	CcSEcCtD
Pemetrexed—Anorexia—Sibutramine—obesity	0.000673	0.00183	CcSEcCtD
Pemetrexed—Angina pectoris—Topiramate—obesity	0.000672	0.00183	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Orlistat—obesity	0.000665	0.00181	CcSEcCtD
Pemetrexed—Loss of consciousness—Bupropion—obesity	0.000663	0.0018	CcSEcCtD
Pemetrexed—Pancytopenia—Topiramate—obesity	0.000655	0.00178	CcSEcCtD
Pemetrexed—Hypertension—Bupropion—obesity	0.000651	0.00177	CcSEcCtD
Pemetrexed—Neutropenia—Topiramate—obesity	0.000645	0.00176	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Sibutramine—obesity	0.000643	0.00175	CcSEcCtD
Pemetrexed—Dyspepsia—Orlistat—obesity	0.000642	0.00175	CcSEcCtD
Pemetrexed—Arthralgia—Bupropion—obesity	0.000642	0.00175	CcSEcCtD
Pemetrexed—Chest pain—Bupropion—obesity	0.000642	0.00175	CcSEcCtD
Pemetrexed—Myalgia—Bupropion—obesity	0.000642	0.00175	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000638	0.00174	CcSEcCtD
Pemetrexed—Decreased appetite—Orlistat—obesity	0.000634	0.00173	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Orlistat—obesity	0.00063	0.00171	CcSEcCtD
Pemetrexed—Dyspnoea—Sibutramine—obesity	0.00063	0.00171	CcSEcCtD
Pemetrexed—Fatigue—Orlistat—obesity	0.000629	0.00171	CcSEcCtD
Pemetrexed—Pain—Orlistat—obesity	0.000624	0.0017	CcSEcCtD
Pemetrexed—Dyspepsia—Sibutramine—obesity	0.000622	0.00169	CcSEcCtD
Pemetrexed—Anaphylactic shock—Bupropion—obesity	0.000616	0.00168	CcSEcCtD
Pemetrexed—Oedema—Bupropion—obesity	0.000616	0.00168	CcSEcCtD
Pemetrexed—Infestation NOS—Topiramate—obesity	0.000615	0.00167	CcSEcCtD
Pemetrexed—Infestation—Topiramate—obesity	0.000615	0.00167	CcSEcCtD
Pemetrexed—Decreased appetite—Sibutramine—obesity	0.000614	0.00167	CcSEcCtD
Pemetrexed—Infection—Bupropion—obesity	0.000612	0.00166	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Topiramate—obesity	0.00061	0.00166	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Sibutramine—obesity	0.00061	0.00166	CcSEcCtD
Pemetrexed—Shock—Bupropion—obesity	0.000606	0.00165	CcSEcCtD
Pemetrexed—Renal failure—Topiramate—obesity	0.000605	0.00165	CcSEcCtD
Pemetrexed—Pain—Sibutramine—obesity	0.000604	0.00164	CcSEcCtD
Pemetrexed—Constipation—Sibutramine—obesity	0.000604	0.00164	CcSEcCtD
Pemetrexed—Nervous system disorder—Bupropion—obesity	0.000604	0.00164	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Topiramate—obesity	0.000603	0.00164	CcSEcCtD
Pemetrexed—Thrombocytopenia—Bupropion—obesity	0.000603	0.00164	CcSEcCtD
Pemetrexed—Stomatitis—Topiramate—obesity	0.0006	0.00163	CcSEcCtD
Pemetrexed—Skin disorder—Bupropion—obesity	0.000598	0.00163	CcSEcCtD
Pemetrexed—Conjunctivitis—Topiramate—obesity	0.000598	0.00163	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Orlistat—obesity	0.000597	0.00162	CcSEcCtD
Pemetrexed—Anorexia—Bupropion—obesity	0.000587	0.0016	CcSEcCtD
Pemetrexed—Urticaria—Orlistat—obesity	0.00058	0.00158	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Sibutramine—obesity	0.000578	0.00157	CcSEcCtD
Pemetrexed—Abdominal pain—Orlistat—obesity	0.000577	0.00157	CcSEcCtD
Pemetrexed—Body temperature increased—Orlistat—obesity	0.000577	0.00157	CcSEcCtD
Pemetrexed—Agranulocytosis—Topiramate—obesity	0.000574	0.00156	CcSEcCtD
Pemetrexed—Urticaria—Sibutramine—obesity	0.000561	0.00153	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Bupropion—obesity	0.000561	0.00153	CcSEcCtD
Pemetrexed—Abdominal pain—Sibutramine—obesity	0.000558	0.00152	CcSEcCtD
Pemetrexed—Body temperature increased—Sibutramine—obesity	0.000558	0.00152	CcSEcCtD
Pemetrexed—Hepatitis—Topiramate—obesity	0.000552	0.0015	CcSEcCtD
Pemetrexed—Dyspnoea—Bupropion—obesity	0.000549	0.00149	CcSEcCtD
Pemetrexed—Pharyngitis—Topiramate—obesity	0.000548	0.00149	CcSEcCtD
Pemetrexed—Urinary tract disorder—Topiramate—obesity	0.000545	0.00148	CcSEcCtD
Pemetrexed—Dyspepsia—Bupropion—obesity	0.000542	0.00147	CcSEcCtD
Pemetrexed—Urethral disorder—Topiramate—obesity	0.000541	0.00147	CcSEcCtD
Pemetrexed—Hypersensitivity—Orlistat—obesity	0.000538	0.00146	CcSEcCtD
Pemetrexed—Decreased appetite—Bupropion—obesity	0.000535	0.00146	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Bupropion—obesity	0.000532	0.00145	CcSEcCtD
Pemetrexed—Fatigue—Bupropion—obesity	0.000531	0.00144	CcSEcCtD
Pemetrexed—Pain—Bupropion—obesity	0.000527	0.00143	CcSEcCtD
Pemetrexed—Constipation—Bupropion—obesity	0.000527	0.00143	CcSEcCtD
Pemetrexed—Asthenia—Orlistat—obesity	0.000524	0.00142	CcSEcCtD
Pemetrexed—Erythema multiforme—Topiramate—obesity	0.000522	0.00142	CcSEcCtD
Pemetrexed—Hypersensitivity—Sibutramine—obesity	0.00052	0.00142	CcSEcCtD
Pemetrexed—Pruritus—Orlistat—obesity	0.000516	0.0014	CcSEcCtD
Pemetrexed—Eye disorder—Topiramate—obesity	0.000516	0.0014	CcSEcCtD
Pemetrexed—Asthenia—Sibutramine—obesity	0.000507	0.00138	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Bupropion—obesity	0.000503	0.00137	CcSEcCtD
Pemetrexed—Pruritus—Sibutramine—obesity	0.0005	0.00136	CcSEcCtD
Pemetrexed—Diarrhoea—Orlistat—obesity	0.000499	0.00136	CcSEcCtD
Pemetrexed—Urticaria—Bupropion—obesity	0.000489	0.00133	CcSEcCtD
Pemetrexed—Alopecia—Topiramate—obesity	0.000488	0.00133	CcSEcCtD
Pemetrexed—Body temperature increased—Bupropion—obesity	0.000487	0.00132	CcSEcCtD
Pemetrexed—Abdominal pain—Bupropion—obesity	0.000487	0.00132	CcSEcCtD
Pemetrexed—Diarrhoea—Sibutramine—obesity	0.000483	0.00131	CcSEcCtD
Pemetrexed—Dizziness—Orlistat—obesity	0.000483	0.00131	CcSEcCtD
Pemetrexed—Erythema—Topiramate—obesity	0.000481	0.00131	CcSEcCtD
Pemetrexed—Malnutrition—Topiramate—obesity	0.000481	0.00131	CcSEcCtD
Pemetrexed—Dysgeusia—Topiramate—obesity	0.000471	0.00128	CcSEcCtD
Pemetrexed—Dizziness—Sibutramine—obesity	0.000467	0.00127	CcSEcCtD
Pemetrexed—Vomiting—Orlistat—obesity	0.000464	0.00126	CcSEcCtD
Pemetrexed—Rash—Orlistat—obesity	0.00046	0.00125	CcSEcCtD
Pemetrexed—Dermatitis—Orlistat—obesity	0.00046	0.00125	CcSEcCtD
Pemetrexed—Hypersensitivity—Bupropion—obesity	0.000454	0.00123	CcSEcCtD
Pemetrexed—Vomiting—Sibutramine—obesity	0.000449	0.00122	CcSEcCtD
Pemetrexed—Rash—Sibutramine—obesity	0.000445	0.00121	CcSEcCtD
Pemetrexed—Dermatitis—Sibutramine—obesity	0.000445	0.00121	CcSEcCtD
Pemetrexed—Anaemia—Topiramate—obesity	0.000444	0.00121	CcSEcCtD
Pemetrexed—Asthenia—Bupropion—obesity	0.000442	0.0012	CcSEcCtD
Pemetrexed—Pruritus—Bupropion—obesity	0.000436	0.00119	CcSEcCtD
Pemetrexed—Nausea—Orlistat—obesity	0.000433	0.00118	CcSEcCtD
Pemetrexed—Syncope—Topiramate—obesity	0.000431	0.00117	CcSEcCtD
Pemetrexed—Leukopenia—Topiramate—obesity	0.00043	0.00117	CcSEcCtD
Pemetrexed—Loss of consciousness—Topiramate—obesity	0.000422	0.00115	CcSEcCtD
Pemetrexed—Diarrhoea—Bupropion—obesity	0.000421	0.00115	CcSEcCtD
Pemetrexed—Nausea—Sibutramine—obesity	0.00042	0.00114	CcSEcCtD
Pemetrexed—Hypertension—Topiramate—obesity	0.000415	0.00113	CcSEcCtD
Pemetrexed—Arthralgia—Topiramate—obesity	0.000409	0.00111	CcSEcCtD
Pemetrexed—Chest pain—Topiramate—obesity	0.000409	0.00111	CcSEcCtD
Pemetrexed—Myalgia—Topiramate—obesity	0.000409	0.00111	CcSEcCtD
Pemetrexed—Dizziness—Bupropion—obesity	0.000407	0.00111	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000406	0.00111	CcSEcCtD
Pemetrexed—Oedema—Topiramate—obesity	0.000392	0.00107	CcSEcCtD
Pemetrexed—Vomiting—Bupropion—obesity	0.000391	0.00107	CcSEcCtD
Pemetrexed—Infection—Topiramate—obesity	0.00039	0.00106	CcSEcCtD
Pemetrexed—Rash—Bupropion—obesity	0.000388	0.00106	CcSEcCtD
Pemetrexed—Dermatitis—Bupropion—obesity	0.000388	0.00106	CcSEcCtD
Pemetrexed—Shock—Topiramate—obesity	0.000386	0.00105	CcSEcCtD
Pemetrexed—Nervous system disorder—Topiramate—obesity	0.000385	0.00105	CcSEcCtD
Pemetrexed—Thrombocytopenia—Topiramate—obesity	0.000384	0.00105	CcSEcCtD
Pemetrexed—Skin disorder—Topiramate—obesity	0.000381	0.00104	CcSEcCtD
Pemetrexed—Anorexia—Topiramate—obesity	0.000374	0.00102	CcSEcCtD
Pemetrexed—Nausea—Bupropion—obesity	0.000366	0.000995	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Topiramate—obesity	0.000357	0.000973	CcSEcCtD
Pemetrexed—Dyspnoea—Topiramate—obesity	0.00035	0.000952	CcSEcCtD
Pemetrexed—Dyspepsia—Topiramate—obesity	0.000345	0.00094	CcSEcCtD
Pemetrexed—Decreased appetite—Topiramate—obesity	0.000341	0.000928	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Topiramate—obesity	0.000339	0.000922	CcSEcCtD
Pemetrexed—Fatigue—Topiramate—obesity	0.000338	0.00092	CcSEcCtD
Pemetrexed—Constipation—Topiramate—obesity	0.000335	0.000913	CcSEcCtD
Pemetrexed—Pain—Topiramate—obesity	0.000335	0.000913	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Topiramate—obesity	0.000321	0.000873	CcSEcCtD
Pemetrexed—Urticaria—Topiramate—obesity	0.000312	0.000848	CcSEcCtD
Pemetrexed—Abdominal pain—Topiramate—obesity	0.00031	0.000844	CcSEcCtD
Pemetrexed—Body temperature increased—Topiramate—obesity	0.00031	0.000844	CcSEcCtD
Pemetrexed—Hypersensitivity—Topiramate—obesity	0.000289	0.000786	CcSEcCtD
Pemetrexed—Asthenia—Topiramate—obesity	0.000281	0.000766	CcSEcCtD
Pemetrexed—Pruritus—Topiramate—obesity	0.000278	0.000755	CcSEcCtD
Pemetrexed—Methotrexate—ALB—obesity	0.000271	0.0185	CrCbGaD
Pemetrexed—Diarrhoea—Topiramate—obesity	0.000268	0.00073	CcSEcCtD
Pemetrexed—Dizziness—Topiramate—obesity	0.000259	0.000706	CcSEcCtD
Pemetrexed—Vomiting—Topiramate—obesity	0.000249	0.000679	CcSEcCtD
Pemetrexed—Rash—Topiramate—obesity	0.000247	0.000673	CcSEcCtD
Pemetrexed—Dermatitis—Topiramate—obesity	0.000247	0.000672	CcSEcCtD
Pemetrexed—Nausea—Topiramate—obesity	0.000233	0.000634	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CD36—obesity	6.73e-05	0.00017	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LPIN1—obesity	6.69e-05	0.000169	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—obesity	6.64e-05	0.000167	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PRKAR2B—obesity	6.62e-05	0.000167	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—FASN—obesity	6.62e-05	0.000167	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BAD—obesity	6.61e-05	0.000167	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—BCHE—obesity	6.59e-05	0.000166	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—DCN—obesity	6.57e-05	0.000166	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOA5—obesity	6.56e-05	0.000165	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—POMC—obesity	6.55e-05	0.000165	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—INS—obesity	6.52e-05	0.000164	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GOT2—obesity	6.49e-05	0.000163	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CPT1A—obesity	6.39e-05	0.000161	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—obesity	6.38e-05	0.000161	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2E1—obesity	6.36e-05	0.00016	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FASN—obesity	6.35e-05	0.00016	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS1—obesity	6.33e-05	0.000159	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PARP1—obesity	6.32e-05	0.000159	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	6.3e-05	0.000159	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NQO1—obesity	6.29e-05	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NAMPT—obesity	6.27e-05	0.000158	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARA—obesity	6.26e-05	0.000158	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CLOCK—obesity	6.26e-05	0.000158	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC22A1—obesity	6.26e-05	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCK—obesity	6.23e-05	0.000157	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—LIPC—obesity	6.23e-05	0.000157	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOC3—obesity	6.19e-05	0.000156	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PRKCB—obesity	6.1e-05	0.000154	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SULT2A1—obesity	6.1e-05	0.000154	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GLP1R—obesity	6.1e-05	0.000154	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—obesity	6.08e-05	0.000153	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AGT—obesity	6.06e-05	0.000153	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—INS—obesity	6.06e-05	0.000153	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CD—obesity	6.05e-05	0.000152	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCG—obesity	6.03e-05	0.000152	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A4—obesity	6.03e-05	0.000152	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CETP—obesity	6.01e-05	0.000151	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DPYD—obesity	6e-05	0.000151	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—obesity	5.97e-05	0.00015	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYCS—obesity	5.95e-05	0.00015	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS1—obesity	5.95e-05	0.00015	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SDC1—obesity	5.94e-05	0.00015	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—obesity	5.94e-05	0.00015	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAV1—obesity	5.89e-05	0.000148	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TCF7L2—obesity	5.88e-05	0.000148	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOA1—obesity	5.87e-05	0.000148	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT2—obesity	5.86e-05	0.000148	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKR1C3—obesity	5.85e-05	0.000147	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GGT1—obesity	5.84e-05	0.000147	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GOT1—obesity	5.84e-05	0.000147	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A4—obesity	5.78e-05	0.000146	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PRKAR2B—obesity	5.77e-05	0.000145	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SCARB1—obesity	5.75e-05	0.000145	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NCOA1—obesity	5.75e-05	0.000145	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DCN—obesity	5.73e-05	0.000144	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3R1—obesity	5.71e-05	0.000144	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—obesity	5.71e-05	0.000144	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—STK11—obesity	5.67e-05	0.000143	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP19A1—obesity	5.67e-05	0.000143	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CD—obesity	5.63e-05	0.000142	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GOT1—obesity	5.6e-05	0.000141	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SREBF1—obesity	5.59e-05	0.000141	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CPT1A—obesity	5.58e-05	0.00014	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SERPINE1—obesity	5.57e-05	0.00014	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PRL—obesity	5.52e-05	0.000139	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NAMPT—obesity	5.47e-05	0.000138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCK—obesity	5.43e-05	0.000137	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LIPC—obesity	5.43e-05	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GOT2—obesity	5.43e-05	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—obesity	5.43e-05	0.000137	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TYK2—obesity	5.41e-05	0.000136	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOC3—obesity	5.4e-05	0.000136	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RHOA—obesity	5.37e-05	0.000135	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—obesity	5.36e-05	0.000135	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—obesity	5.36e-05	0.000135	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FASN—obesity	5.32e-05	0.000134	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3R1—obesity	5.32e-05	0.000134	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—obesity	5.32e-05	0.000134	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—obesity	5.3e-05	0.000134	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—obesity	5.3e-05	0.000133	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CB—obesity	5.27e-05	0.000133	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—COMT—obesity	5.27e-05	0.000133	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FOXO3—obesity	5.25e-05	0.000132	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CETP—obesity	5.24e-05	0.000132	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—obesity	5.23e-05	0.000132	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNB3—obesity	5.19e-05	0.000131	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARGC1A—obesity	5.19e-05	0.000131	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SDC1—obesity	5.18e-05	0.000131	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARG—obesity	5.18e-05	0.00013	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—obesity	5.17e-05	0.00013	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—obesity	5.15e-05	0.00013	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2E1—obesity	5.11e-05	0.000129	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POMC—obesity	5.1e-05	0.000129	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKR1C3—obesity	5.1e-05	0.000128	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—INS—obesity	5.08e-05	0.000128	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNAS—obesity	5.06e-05	0.000127	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NQO1—obesity	5.05e-05	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SCARB1—obesity	5.02e-05	0.000126	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOB—obesity	4.95e-05	0.000125	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CB—obesity	4.91e-05	0.000124	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTOR—obesity	4.91e-05	0.000124	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SREBF1—obesity	4.87e-05	0.000123	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—obesity	4.86e-05	0.000122	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A4—obesity	4.84e-05	0.000122	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCG—obesity	4.84e-05	0.000122	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYCS—obesity	4.78e-05	0.00012	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOB—obesity	4.75e-05	0.00012	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GOT2—obesity	4.74e-05	0.000119	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—obesity	4.74e-05	0.000119	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—LPL—obesity	4.73e-05	0.000119	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CD—obesity	4.71e-05	0.000119	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GGT1—obesity	4.69e-05	0.000118	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GOT1—obesity	4.69e-05	0.000118	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—obesity	4.65e-05	0.000117	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FASN—obesity	4.64e-05	0.000117	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—obesity	4.64e-05	0.000117	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—obesity	4.62e-05	0.000116	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOA1—obesity	4.62e-05	0.000116	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—obesity	4.61e-05	0.000116	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—STK11—obesity	4.55e-05	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP19A1—obesity	4.55e-05	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Disease—LPL—obesity	4.54e-05	0.000114	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FOXO1—obesity	4.51e-05	0.000114	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CD36—obesity	4.49e-05	0.000113	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2E1—obesity	4.46e-05	0.000112	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3R1—obesity	4.45e-05	0.000112	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—obesity	4.45e-05	0.000112	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NQO1—obesity	4.41e-05	0.000111	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—obesity	4.26e-05	0.000107	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—COMT—obesity	4.23e-05	0.000107	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A4—obesity	4.23e-05	0.000106	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCG—obesity	4.23e-05	0.000106	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PRKCD—obesity	4.18e-05	0.000105	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARA—obesity	4.18e-05	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNB3—obesity	4.17e-05	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARGC1A—obesity	4.17e-05	0.000105	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYCS—obesity	4.17e-05	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—obesity	4.16e-05	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—obesity	4.12e-05	0.000104	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CB—obesity	4.11e-05	0.000104	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GGT1—obesity	4.09e-05	0.000103	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GOT1—obesity	4.09e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—obesity	4.09e-05	0.000103	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—obesity	4.07e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNAS—obesity	4.06e-05	0.000102	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AGT—obesity	4.05e-05	0.000102	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOA1—obesity	4.03e-05	0.000102	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOB—obesity	3.98e-05	0.0001	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—STK11—obesity	3.97e-05	0.0001	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP19A1—obesity	3.97e-05	0.0001	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—obesity	3.96e-05	9.99e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAV1—obesity	3.93e-05	9.89e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOA1—obesity	3.92e-05	9.87e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS2—obesity	3.89e-05	9.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—obesity	3.8e-05	9.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—LPL—obesity	3.8e-05	9.57e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—obesity	3.79e-05	9.55e-05	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—obesity	3.79e-05	9.55e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CAV1—obesity	3.77e-05	9.49e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOA1—obesity	3.76e-05	9.47e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—obesity	3.71e-05	9.34e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—COMT—obesity	3.69e-05	9.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—obesity	3.68e-05	9.28e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARGC1A—obesity	3.64e-05	9.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNB3—obesity	3.64e-05	9.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—obesity	3.63e-05	9.13e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CD36—obesity	3.61e-05	9.1e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—obesity	3.59e-05	9.05e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—obesity	3.58e-05	9.01e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNAS—obesity	3.55e-05	8.93e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BAD—obesity	3.54e-05	8.93e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—obesity	3.52e-05	8.88e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—obesity	3.51e-05	8.85e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOB—obesity	3.47e-05	8.75e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARG—obesity	3.45e-05	8.7e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—obesity	3.42e-05	8.62e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—POMC—obesity	3.41e-05	8.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS1—obesity	3.39e-05	8.55e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—INS—obesity	3.39e-05	8.53e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARA—obesity	3.36e-05	8.46e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LPL—obesity	3.32e-05	8.35e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AGT—obesity	3.25e-05	8.19e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—INS—obesity	3.25e-05	8.19e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—obesity	3.24e-05	8.15e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—obesity	3.22e-05	8.1e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—obesity	3.21e-05	8.09e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—obesity	3.19e-05	8.03e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAV1—obesity	3.16e-05	7.95e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CD36—obesity	3.15e-05	7.94e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOA1—obesity	3.15e-05	7.93e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CD—obesity	3.15e-05	7.92e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT2—obesity	3.14e-05	7.91e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—obesity	3.1e-05	7.82e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CD—obesity	3.02e-05	7.6e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—obesity	2.99e-05	7.53e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—obesity	2.99e-05	7.52e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SERPINE1—obesity	2.99e-05	7.52e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3R1—obesity	2.97e-05	7.48e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—obesity	2.97e-05	7.48e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARA—obesity	2.93e-05	7.38e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TYK2—obesity	2.9e-05	7.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RHOA—obesity	2.88e-05	7.25e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—obesity	2.88e-05	7.24e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3R1—obesity	2.85e-05	7.18e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—obesity	2.85e-05	7.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AGT—obesity	2.84e-05	7.15e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—obesity	2.78e-05	7e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—obesity	2.77e-05	6.99e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAV1—obesity	2.75e-05	6.94e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOA1—obesity	2.75e-05	6.92e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CB—obesity	2.74e-05	6.91e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POMC—obesity	2.74e-05	6.89e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—INS—obesity	2.72e-05	6.86e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—obesity	2.72e-05	6.84e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—obesity	2.65e-05	6.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTOR—obesity	2.63e-05	6.63e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CB—obesity	2.63e-05	6.63e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—obesity	2.63e-05	6.62e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—obesity	2.61e-05	6.57e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CD—obesity	2.53e-05	6.37e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—obesity	2.51e-05	6.32e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—obesity	2.5e-05	6.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—obesity	2.5e-05	6.29e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—obesity	2.44e-05	6.15e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—obesity	2.42e-05	6.1e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POMC—obesity	2.39e-05	6.02e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—obesity	2.39e-05	6.01e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3R1—obesity	2.39e-05	6.01e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—INS—obesity	2.37e-05	5.98e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CD—obesity	2.21e-05	5.56e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CB—obesity	2.2e-05	5.55e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—obesity	2.18e-05	5.5e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—obesity	2.18e-05	5.48e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—obesity	2.08e-05	5.25e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3R1—obesity	2.08e-05	5.25e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—obesity	2.05e-05	5.15e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—obesity	2.03e-05	5.12e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CB—obesity	1.92e-05	4.84e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—obesity	1.9e-05	4.8e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—obesity	1.89e-05	4.76e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—obesity	1.88e-05	4.75e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—obesity	1.67e-05	4.21e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—obesity	1.6e-05	4.04e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—obesity	1.42e-05	3.58e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—obesity	1.37e-05	3.44e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—obesity	1.34e-05	3.38e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—obesity	1.31e-05	3.3e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—obesity	1.17e-05	2.95e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—obesity	1.1e-05	2.76e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—obesity	9.57e-06	2.41e-05	CbGpPWpGaD
